Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study.

PMID: 33704620
Journal: INVESTIGATIONAL NEW DRUGS
Year: 2021
Reference: Invest New Drugs. 2021 Oct;39(5):1275-1283. doi: 10.1007/s10637-020-01025-x. Epub 2021 Mar 11.
Impact factor:
Publication type: Paper in international publication
Authors: Brana, Irene; Calvo, Emiliano; Cullell-Young, Martin; de Miguel, Maria; Doger, Bernard; Flynn, Michael; Forster, Martin; Kahatt, Carmen; Lopez-Criado, Maria Pilar; Lopez-Vilarino, Jose Antonio et al.
DOI: 10.1007/s10637-020-01025-x

Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial.

PMID: 34295395
Journal: Breathe (Sheffield, England)
Year: 2021
Reference: Breathe (Sheff). 2021 Mar;17(1):200279. doi: 10.1183/20734735.0279-2020.
Impact factor: 0
Publication type: Letter or abstract
Authors: Pilia, Maria Florencia, Ojanguren, Inigo et al.
DOI: 10.1183/20734735.0279-2020

Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial.

PMID: 34295395
Journal: Breathe (Sheffield, England)
Year: 2021
Reference: Breathe (Sheff). 2021 Mar;17(1):200279. doi: 10.1183/20734735.0279-2020.
Impact factor:
Publication type: Letter or abstract
Authors: Ojanguren, Inigo; Pilia, Maria Florencia et al.
DOI: 10.1183/20734735.0279-2020

Efficacy and safety of opioid therapy guided by pharmacogenetics: a systematic review.

PMID: 34013775
Journal: PHARMACOGENOMICS
Year: 2021
Reference: Pharmacogenomics. 2021 Jun;22(9):573-586. doi: 10.2217/pgs-2021-0021. Epub 2021 May 20.
Impact factor: 2.533
Publication type: Review in international publication
Authors: Rodriguez Cairoli, Federico, Appiani, Francisco, Sambade, Juan Manuel, Comande, Daniel, Camacho Arteaga, Lina, Ciapponi, Agustin et al.
DOI: 10.2217/pgs-2021-0021

Efficacy and safety of opioid therapy guided by pharmacogenetics: a systematic review.

PMID: 34013775
Journal: PHARMACOGENOMICS
Year: 2021
Reference: Pharmacogenomics. 2021 Jun;22(9):573-586. doi: 10.2217/pgs-2021-0021. Epub 2021 May 20.
Impact factor:
Publication type: Review in international publication
Authors: Appiani, Francisco; Camacho Arteaga, Lina; Camacho Arteaga, Lina; Ciapponi, Agustin; Comande, Daniel; Rodriguez Cairoli, Federico; Sambade, Juan Manuel et al.
DOI: 10.2217/pgs-2021-0021

Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome.

PMID: 33426389
Journal: Kidney International Reports
Year: 2021
Reference: Kidney Int Rep. 2020 Oct 12;6(1):101-109. doi: 10.1016/j.ekir.2020.09.046. eCollection 2021 Jan.
Impact factor: 4.164
Publication type: Paper in international publication
Authors: Jatem, Elias, Lima, Joan, Montoro, Bruno, Torres-Bondia, Francisco, Segarra, Alfons et al.
DOI: 10.1016/j.ekir.2020.09.046

Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome.

PMID: 33426389
Journal: Kidney International Reports
Year: 2021
Reference: Kidney Int Rep. 2020 Oct 12;6(1):101-109. doi: 10.1016/j.ekir.2020.09.046. eCollection 2021 Jan.
Impact factor:
Publication type: Paper in international publication
Authors: Jatem, Elias; Lima, Joan; Montoro, Bruno; Segarra, Alfons; Torres-Bondia, Francisco et al.
DOI: 10.1016/j.ekir.2020.09.046

Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study.

PMID: 33836153
Journal: Lancet Respiratory Medicine
Year: 2021
Reference: Lancet Respir Med. 2021 Jun;9(6):613-621. doi: 10.1016/S2213-2600(20)30515-4. Epub 2021 Apr 6.
Impact factor: 30.7
Publication type: Paper in international publication
Authors: Yap, Timothy A, Nakagawa, Kazuhiko, Fujimoto, Nobukazu, Kuribayashi, Kozo, Guren, Tormod Kyrre, Shapira-Frommer, Ronnie, Gao, Bo, Kao, Steven, Matos, Ignacio, Planchard, David et al.
DOI: 10.1016/S2213-2600(20)30515-4

Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study.

PMID: 33836153
Journal: Lancet Respiratory Medicine
Year: 2021
Reference: Lancet Respir Med. 2021 Jun;9(6):613-621. doi: 10.1016/S2213-2600(20)30515-4. Epub 2021 Apr 6.
Impact factor:
Publication type: Paper in international publication
Authors: Calabro, Luana; Chatterjee, Arkendu; Fujimoto, Nobukazu; Gao, Bo; Guren, Tormod Kyrre; Jin, Fan; Kao, Steven; Kindler, Hedy L; Kuribayashi, Kozo; Matos, Ignacio et al.
DOI: 10.1016/S2213-2600(20)30515-4

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).

PMID: 34030643
Journal: BMC CANCER
Year: 2021
Reference: BMC Cancer. 2021 May 24;21(1):593. doi: 10.1186/s12885-021-08085-z.
Impact factor: 4.43
Publication type: Paper in international publication
Authors: Grivas, P, Loriot, Y, Morales-Barrera, R, Teo, M Y, Zakharia, Y, Feyerabend, S, Vogelzang, N J, Grande, E, Adra, N, Alva, A et al.
DOI: 10.1186/s12885-021-08085-z

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).

PMID: 34030643
Journal: BMC CANCER
Year: 2021
Reference: BMC Cancer. 2021 May 24;21(1):593. doi: 10.1186/s12885-021-08085-z.
Impact factor:
Publication type: Paper in international publication
Authors: Adra, N; Alva, A; Chowdhury, S; Dusek, R L; Feyerabend, S; Grande, E; Grivas, P; Gupta, S; Josephs, D H; Loehr, A et al.
DOI: 10.1186/s12885-021-08085-z

Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial.

PMID: 34358497
Journal: Lancet HIV
Year: 2021
Reference: Lancet HIV. 2021 Aug;8(8):e463-e473. doi: 10.1016/S2352-3018(21)00100-4.
Impact factor: 12.767
Publication type: Paper in international publication
Authors: Rojas, Jhon, de Lazzari, Elisa, Negredo, Eugenia, Domingo, Pere, Tiraboschi, Juan, Ribera, Esteve, Abdulghani, Nadia, Podzamczer, Daniel, Gutierrez, Maria M, Paredes, Roger et al.
DOI: 10.1016/S2352-3018(21)00100-4

Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial.

PMID: 34358497
Journal: Lancet HIV
Year: 2021
Reference: Lancet HIV. 2021 Aug;8(8):e463-e473. doi: 10.1016/S2352-3018(21)00100-4.
Impact factor:
Publication type: Paper in international publication
Authors: Abdulghani, Nadia; Blanco, Jose L; Clotet, Bonaventura; de Lazzari, Elisa; Domingo, Pere; Gatell, Jose M; Gutierrez, Maria M; Martinez, Esteban; Mateo, Maria G; Negredo, Eugenia et al.
DOI: 10.1016/S2352-3018(21)00100-4

Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.

PMID: 34244703
Journal: JAMA Neurology
Year: 2021
Reference: JAMA Neurol. 2021 Sep 1;78(9):1091-1098. doi: 10.1001/jamaneurol.2021.2440.
Impact factor: 18.302
Publication type: Paper in international publication
Authors: Hu, Bo, Gomez Schneider, Maia, Pigretti, Santiago, Lipovestky, Fernando, Zurru, Maria C, Davis, Stephen, Wong, Andrew, Wijeratne, Tissa, Sabet, Arman, Lee, Andrew et al.
DOI: 10.1001/jamaneurol.2021.2440

Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.

PMID: 34244703
Journal: JAMA Neurology
Year: 2021
Reference: JAMA Neurol. 2021 Sep 1;78(9):1091-1098. doi: 10.1001/jamaneurol.2021.2440.
Impact factor:
Publication type: Paper in international publication
Authors: Adami, Alessandro; Adrasetty, Gopal R; Agnelli, Giancarlo; Ahmed, Niaz; Akhmadeeva, Leila; Aksentiev, Sergei; Al-Senani, Fahmi; Alamowitch, Sonia; Alghamdi, Saeed; Alhussein, Fawaz et al.
DOI: 10.1001/jamaneurol.2021.2440

Efficacy and safety of TOBI Podhaler(R) in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study.

PMID: 32855225
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2021
Reference: Eur Respir J. 2021 Jan 5;57(1). pii: 13993003.01451-2020. doi: 10.1183/13993003.01451-2020. Print 2021 Jan.
Impact factor: 16.671
Publication type: Paper in international publication
Authors: Loebinger, Michael R, Polverino, Eva, Chalmers, James D, Tiddens, Harm A W M, Goossens, Herman, Tunney, Michael, Ringhausen, Felix C, Hill, Adam T, Pathan, Rashidkhan, Angyalosi, Gerhild et al.
DOI: 10.1183/13993003.01451-2020

Efficacy and safety of TOBI Podhaler(R) in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study.

PMID: 32855225
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2021
Reference: Eur Respir J. 2021 Jan 5;57(1). pii: 13993003.01451-2020. doi: 10.1183/13993003.01451-2020. Print 2021 Jan.
Impact factor:
Publication type: Paper in international publication
Authors: Angyalosi, Gerhild; Blasi, Francesco; Chalmers, James D; Elborn, Stuart J; Goossens, Herman; Haworth, Charles S; Hill, Adam T; Loebinger, Michael R; Pathan, Rashidkhan; Polverino, Eva et al.
DOI: 10.1183/13993003.01451-2020

Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery.

PMID: 34857831
Journal: Scientific Reports
Year: 2021
Reference: Sci Rep. 2021 Dec 2;11(1):23358. doi: 10.1038/s41598-021-02694-1.
Impact factor: 4.38
Publication type: Paper in international publication
Authors: Kagiava, A, Richter, J, Tryfonos, C, Leal-Julia, M, Sargiannidou, I, Christodoulou, C, Bosch, A, Kleopa, K A et al.
DOI: 10.1038/s41598-021-02694-1

Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery.

PMID: 34857831
Journal: Scientific Reports
Year: 2021
Reference: Sci Rep. 2021 Dec 2;11(1):23358. doi: 10.1038/s41598-021-02694-1.
Impact factor:
Publication type: Paper in international publication
Authors: Bosch, A; Christodoulou, C; Kagiava, A; Kleopa, K A; Leal-Julia, M; Richter, J; Sargiannidou, I; Tryfonos, C et al.
DOI: 10.1038/s41598-021-02694-1

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort.

PMID: 34725384
Journal: Scientific Reports
Year: 2021
Reference: Sci Rep. 2021 Nov 1;11(1):21357. doi: 10.1038/s41598-021-00831-4.
Impact factor:
Publication type: Paper in international publication
Authors: Amat, Ramon; Assaf, Juan-David; Callejo, Ana; Carbonell, Caterina; Cedres, Susana; Dienstmann, Rodrigo; Felip, Enriqueta; Frigola, Joan; Iranzo, Patricia; Marmolejo, David et al.
DOI: 10.1038/s41598-021-00831-4

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.

PMID: 33480963
Journal: JAMA Oncology
Year: 2021
Reference: JAMA Oncol. 2021 Apr 1;7(4):573-584. doi: 10.1001/jamaoncol.2020.7932.
Impact factor: 31.777
Publication type: Paper in international publication
Authors: Im, Seock-Ah, Rugo, Hope S, Gradishar, William J, Rock, Edwin P, Hong, Shengyan, Koenig, Scott, Curigliano, Giuseppe, Musolino, Antonino, Pegram, Mark D, Wright, Gail S et al.
DOI: 10.1001/jamaoncol.2020.7932

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.

PMID: 33480963
Journal: JAMA Oncology
Year: 2021
Reference: JAMA Oncol. 2021 Apr 1;7(4):573-584. doi: 10.1001/jamaoncol.2020.7932.
Impact factor:
Publication type: Paper in international publication
Authors: Bonvini, Ezio; Brown-Glaberman, Ursa; Cardoso, Fatima; Cortes, Javier; Curigliano, Giuseppe; de Boer, Maaike; De Laurentiis, Michelino; Edlich, Sutton; Escriva-de-Romani, Santiago; Fasching, Peter A et al.
DOI: 10.1001/jamaoncol.2020.7932

Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.

PMID: 32376758
Journal: BMJ Supportive & Palliative Care
Year: 2021
Reference: BMJ Support Palliat Care. 2021 Mar;11(1):25-31. doi: 10.1136/bmjspcare-2020-002249. Epub 2020 May 6.
Impact factor: 3.568
Publication type: Paper in international publication
Authors: Garcia Navalon, Francisco, Cobo Dols, Manuel, Beato Zambrano, Carmen, Cabezon Gutierrez, Luis, Chicas Sett, Rodolfo, Blancas Lopez-Barajas, Maria Isabel, Togores Torres, Pilar, Delgado Mingorance, Ignacio, Giraldo Marin, Alexandra, Libran Oriol, Anna et al.
DOI: 10.1136/bmjspcare-2020-002249

Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.

PMID: 32376758
Journal: BMJ Supportive & Palliative Care
Year: 2021
Reference: BMJ Support Palliat Care. 2021 Mar;11(1):25-31. doi: 10.1136/bmjspcare-2020-002249. Epub 2020 May 6.
Impact factor:
Publication type: Paper in international publication
Authors: Beato Zambrano, Carmen; Blancas Lopez-Barajas, Maria Isabel; Cabezon Gutierrez, Luis; Chicas Sett, Rodolfo; Cobo Dols, Manuel; Delgado Mingorance, Ignacio; Firvida Perez, Jose Luis; Garcia Navalon, Francisco; Giraldo Marin, Alexandra; Higuera Gomez, Oliver et al.
DOI: 10.1136/bmjspcare-2020-002249